The synthesis and characterisation of the reactive tetrakis(0,O-phosphorus)-bridged calix[4]resorcinols 3 and 4 is described. Because of its poor solubility in common organic solvents, a solid-state NMR investigation of 3 (lH, 13C, 'lP) was conducted. Reaction of 3 with MeMgI, Me,SiNMe2, and HNMe2 furnished the 03h3P-substituted cavitands 5 and 6. Oxidative addition reactions of 6 with the (H2N)2C(=O)/H202(1: 1) adduct, tetrachloro-o-benzoquinone (TOB), and hexafluoroacetone (HFA) led to the n4h5P derivative 7, and to the n5h5P derivatives 8 and 9. An X-ray crystal-structure determination of the tetrakis(0,O-phosphorus)-bridged calix[4]resorcinol 4 has been conducted. The framework displays the cone conformation; the chlorine atoms are directed inwards.
The octakis(trimethylsiloxy)calix[4]resorcinarenes, 3 and 4, were synthesized by reaction of 1 and its tetrabromo derivative 2 with hexamethyldisilazane, and were found to exhibit dynamic behaviour in solution. Temperature-dependent NMR investigations confirmed the presence of at least two conformational isomers of 3 in solution. The conformation of 3 in the solid state was determined by an X-ray crystal structure analysis; the calixarene displays a boat conformation. The introduction of the ethoxy group as a spacer into the molecule of 1 was effected via its reaction with ethyl bromoacetate and subsequent reduction with lithium aluminium hydride forming the ethoxy-tethered C-methylcalix[4]resorcinarene 6 in an impure state. Reaction of crude 6 with hexamethyldisilazane furnished the ethoxy-tethered octakis( trimethylsiloxy)calix[4]resorcinarene 7; its hydrolysis led to pure 6.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.